Crossmark

Quadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection

Crossref DOI link: https://doi.org/10.1016/j.medcle.2016.05.051

Published Print: 2016-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Campillo, Ana

Ostiz, Miriam

Amorena, Edurne

Kutz, Marcos

La Iglesia, Matilde
License Information

Text and Data Mining valid from 2016-09-01
More Information

This article is maintained by: Elsevier

Article Title: Quadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2016.05.051

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2016.05.017

Content Type: simple-article

Copyright: © 2016 Elsevier España, S.L.U. All rights reserved.